The upside case depends on Serve evolving from a robot operator into the workflow owner around each mission. If delivery density recovers, hospitals become a steadier second engine, and more revenue shifts toward recurring software, trust, and advertising layers, the market can pay a healthy growth multiple even without pure-software margins. I do not underwrite a premium frontier-AI
rerating because channel power and regulation remain real limits.